Abstract
"Autologous Expanded Mesenchymal Stem Cell Implantation for Orthopedics Conditions as a Non- Surgical Approach"
Highlights
This article aims to address best practices in regenerative medicine using autologous expanded mesenchymal stem cells (MSCs) combined with platelet-rich plasma (PRP)
We summarize our findings from various literature reviews and our experience using combined fat-derived expanded MSCs-PRP therapy in many hundreds of clients for osteoarthritis (OA) and tendinopathy, namely tendon tear(s)
The doses we use in large areas ranging between 50-100 million MSCs in 2 MLS of fluid combined with 5-8 MLS of PRP in the same syringe depending on the size of the area(s), but in smaller joints, we modify the number of cells and PRP volume
Summary
This article aims to address best practices in regenerative medicine using autologous expanded mesenchymal stem cells (MSCs) combined with platelet-rich plasma (PRP). We summarize our findings from various literature reviews and our experience using combined fat-derived expanded MSCs-PRP therapy in many hundreds of clients for osteoarthritis (OA) and tendinopathy, namely tendon tear(s). The doses we use in large areas ranging between 50-100 million MSCs in 2 MLS of fluid combined with 5-8 MLS of PRP in the same syringe depending on the size of the area(s), but in smaller joints, we modify the number of cells and PRP volume.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
